A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans

Research output: Journal contributionsJournal articlesResearchpeer-review


  • Bettina Scholtka
  • Mandy Schneider
  • Ralph Melcher
  • Tiemo Katzenberger
  • Daniela Friedrich
  • Kornelia Berghof-Jäger
  • Wolfgang Scheppach
  • Pablo Steinberg

Background: Very recently a gene marker panel that allows the mutational analysis of APC, CTNNB1, B-RAF and K-RAS was conceived. The aim of the present study was to use the 4-gene marker panel covering the Wnt and Ras-Raf-MEK-MAPK signalling pathways to determine the percentage of sporadic colorectal carcinomas (CRC) carrying at least one of the four above-mentioned genes in a mutated form alone and/or in combination with microsatellite instability (MSI) and to compare the sensitivity of the gene marker panel used in this study with that of gene marker panels previously reported in the scientific literature. Methods: CTNNB1 and B-RAF were screened by PCR-single-strand conformation polymorphism analysis and K-RAS gene mutations by restriction fragment length polymorphism analysis. For the mutational analysis of the APC gene mutation cluster region (codons 1243-1567) direct DNA sequencing was performed. The U.S. National Cancer Institute microsatellite panel (BAT25, BAT26, D2S123, D5S346 and D17S250) was used for MSI analysis. Results: It could be shown that about 80% of early stage CRC (UICC stages I and II) and over 90% of CRC in the UICC stage IV carried at least one mutated gene and/or showed MSI. No significant increase in the gene mutation frequencies could be determined when comparing tumours in the UICC stage I with those in UICC stage IV. Conclusions: When compared with previously published gene marker panels the 4-gene marker panel used in the present study shows an excellent performance, allowing to detect genetic alterations in 80-90% of human sporadic CRC samples analyzed.

Translated title of the contributionDetektion von Genmutationen in 80 % der frühen Darmkrebsstadien (UICC I) mittels eines Multitarget-DNA-Assays, der den Wnt-Signalweg und die Ras-Raf-MEK-MAPK-Kaskade abdeckt
Original languageEnglish
JournalCancer Epidemiology
Issue number2
Pages (from-to)123-129
Number of pages7
Publication statusPublished - 08.2009